NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
Clinical trials for NON-SQUAMOUS NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-SQUAMOUS NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NON-SQUAMOUS NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug IDP-001 tested against advanced cancers
Disease control Not yet recruitingThis study tests a new drug called IDP-001 in people with advanced or spreading solid tumors, including lung, head and neck, esophageal, cervical, and skin cancers. The goal is to see if the drug is safe, how the body processes it, and whether it can shrink tumors. About 132 adul…
Matched conditions: NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: InduPro, Inc. • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
New combo therapy aims to outperform standard lung cancer treatment
Disease control Not yet recruitingThis study tests a new drug called HB0025 combined with chemotherapy against a standard treatment (tislelizumab plus chemo) for people with advanced nonsquamous non-small cell lung cancer that cannot be removed by surgery. About 500 adults aged 18 to 75 will receive either treatm…
Matched conditions: NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC